Bio Pharma Dive
JUNE 10, 2024
Of the changes sparked by value-based care, perhaps the most valuable for the biopharmaceutical industry to embrace is the use of health economics and outcomes research (HEOR) to better understand a product’s value.
Pharmaceutical Technology
JUNE 10, 2024
SNS-101 is a monoclonal antibody commercialized by Sensei Biotherapeutics, with a leading Phase II program in Non-Small Cell Lung Cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JUNE 10, 2024
Positive results from the trial could position Moderna to bring the two-in-one vaccine to market in 2025.
Pharmaceutical Technology
JUNE 10, 2024
PYX-201 is a monoclonal antibody conjugated commercialized by Pyxis Oncology, with a leading Phase I program in Thyroid Cancer.
Bio Pharma Dive
JUNE 10, 2024
The expert committee concluded donanemab’s benefits outweigh its risks, despite some concern over the drug’s safety.
Pharmaceutical Technology
JUNE 10, 2024
Enhance drug effectiveness with isotope-enriched compounds! Discover how Shanghai Junshi Bioscience's patented technology improves therapeutic outcomes for PI3K mediated diseases.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 10, 2024
Discover Kodiak Sciences Inc's innovative method for treating wet age-related macular degeneration with an anti-VEGF antibody conjugate. Patented approach offers extended therapeutic effects for at least 12 weeks, providing a less frequent treatment option.
Bio Pharma Dive
JUNE 10, 2024
The offering will help fund Phase 3 tests of a drug the biotech claims could be more selective and potent than Bristol’s TYK2 inhibitor.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Ikena Oncology Inc for treating cancer with specific compounds and compositions. Learn about the innovative method targeting TEAD expression and YAP localization in various types of cancer.
BioSpace
JUNE 10, 2024
While more programs now involve candidates with different targets, experts say anti-amyloid therapies will remain a primary player in treating the memory-robbing disease.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JUNE 10, 2024
Revolutionize motion tracking with Sword Health Inc's patented method using sound and electromagnetic waves. Accurately track user motion with sensors, antennas, and microphones. Explore the innovative system outlined in US11960791B2 for precise tracking and user control.
BioSpace
JUNE 10, 2024
LSD, ketamine, ibogaine and related treatments are moving forward in clinical trials for substance use disorders, including alcohol use disorder and opioid use disorder.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Tenaya Therapeutics Inc for compounds inhibiting HDAC6 activity, offering potential treatments for various diseases. Explore the detailed chemical formula and structural insights in this comprehensive overview.
BioSpace
JUNE 10, 2024
The FDA on Friday approved GSK’s application to use Arexvy to vaccinate adults aged 50 to 59 years who are at increased risk of developing severe respiratory syncytial virus.
Pharmaceutical Technology
JUNE 10, 2024
Discover Cue Biopharma Inc's innovative patent for treating cancer with immune checkpoint inhibitors and protein compositions targeting specific epitopes. Enhance cancer treatment efficacy with this groundbreaking approach.
Antidote
JUNE 10, 2024
Also known as endometrial carcinoma or uterine cancer, endometrial cancer occurs when the cells that line the uterus begin growing uncontrollably. Though the mortality rates are relatively low due to the high rate of early detection, it is a cancer that impacts nearly 70,000 people every year.
Pharmaceutical Technology
JUNE 10, 2024
Discover Vir Biotechnology's groundbreaking patent for a monoclonal antibody targeting Staphylococcus aureus infections. Learn how this innovative composition binds to key proteins for potential treatment.
BioSpace
JUNE 10, 2024
Moderna’s combination vaccine candidate for COVID-19 and influenza outperformed licensed vaccines in older adults, according to late-stage results reported on Monday.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JUNE 10, 2024
Discover how AbCellera Biologics Inc's patented transgenic mouse with a unique LDH expression cassette revolutionizes immunoglobulin library production, enabling extended HCDR3 regions. Explore the groundbreaking genetic modifications enhancing antibody engineering.
BioSpace
JUNE 10, 2024
Lilly’s tirzepatide achieved an absence of metabolic dysfunction-associated steatohepatitis without the worsening of fibrosis in more than 50% of patients in a mid-stage study, the company reported Saturday.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by RAPT Therapeutics Inc for pyrazole pyrimidine compounds targeting HPK1, offering hope for treating cancer and other diseases. Explore the wide-ranging potential of this innovative compound today!
pharmaphorum
JUNE 10, 2024
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Aligos Therapeutics for compounds targeting hepatitis B and D. Learn about the innovative methods for treatment and synthesis.
BioSpace
JUNE 10, 2024
While a prolonged, 15-day regimen of Paxlovid is safe, it appears to be ineffective at lowering the symptoms of long COVID, according to results of a Phase II trial funded by Pfizer and conducted by Stanford Medicine.
Pharmaceutical Technology
JUNE 10, 2024
Clinical trial supply chains have experienced significant changes in recent years. We identify the four key trends.
BioSpace
JUNE 10, 2024
In an SEC filing on Friday, Alumis said it aims to start late-stage trials of a TYK2 inhibitor in plaque psoriasis this year and is seeking public funding for the studies.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JUNE 10, 2024
All eleven members of an FDA advisory committee voted yes in favour of approving Lilly’s donanemab for the treatment of Alzheimer’s disease.
Fierce Pharma
JUNE 10, 2024
As the year rolls on, GSK continues to knock out personal injury lawsuits in the long-running legal saga over whether the popular heartburn medication Zantac can cause cancer. | Plaintiff Eugenia Kasza, who alleged her use of Zantac caused her to develop breast cancer, has voluntarily dismissed her case against GSK. The case was set to start trial in Illinois state court on Monday.
Pharmaceutical Technology
JUNE 10, 2024
Ipsen has expanded its ongoing oncology research partnership with Marengo Therapeutics to advance precision precision T cell engagers (TCE).
BioSpace
JUNE 10, 2024
Despite concerns raised in FDA briefing documents about Eli Lilly’s Alzheimer’s treatment, donanemab, the committee concluded that the benefits outweighed the risks.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
260 
Let's personalize your content